Cited by 433Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusBacterial Genetics and Biotechnology

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Mechanisms of Antibiotic Resistance

Munita, Jose M., Arias, Cesar A.·2016·Virulence Mechanisms of Bacterial Pathogens

DOI 10.1128/9781555819286.ch17

Open this paper in CoChat — free account

Abstract

The discovery, commercialization, and routine administration of antimicrobial compounds to treat infections revolutionized modern medicine and changed the therapeutic paradigm. Indeed, antibiotics have become one of the most important medical interventions needed for the development of complex medical approaches such as cutting-edge surgical procedures, solid organ transplantation, and management of patients with cancer, among others. Unfortunately, the marked increase in antimicrobial resistance among common bacterial pathogens is now threatening this therapeutic accomplishment, jeopardizing the successful outcomes of critically ill patients. In fact, the World Health Organization has named antibiotic resistance as one of the three most important public health threats of the 21st century (1).

Integrity signals

Registry

Crossref · 10.1128/9781555819286.ch17

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Mechanisms of, and Barriers to, Horizontal Gene Transfer between Bacteria
Thomas, C. M., & Nielsen, K. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1234 · Cited by 2,194
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Self-citation
Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,504
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
An Enzyme from Bacteria able to Destroy Penicillin
Abraham, E. P., & Chain, E. B. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,335
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
Walsh, T. R., Weeks, J. L., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,255
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. “. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,128
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, Á., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,112
Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
OXA β-Lactamases
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 817
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, Š., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 803
Intrinsic and acquired resistance mechanisms in enterococcus
Hollenbeck, B. L., & Rice, L. B. (2012) · Virulence · doi:10.4161/viru.21282 · Cited by 795
Mechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Self-citation
Structure of the AcrAB–TolC multidrug efflux pump
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene‐Agyei, T., Venter, H., Chiu, W., & Luisi, B. F. (2014) · Nature · doi:10.1038/nature13205 · Cited by 702
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 666
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 614
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
RifamycinMode of Action, Resistance, and Biosynthesis
Floss, H. G., & Yu, T.-W. (2005) · Chemical Reviews · doi:10.1021/cr030112j · Cited by 547
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
DiazGranados, C. A., Zimmer, S. M., Mitchel, K., & Jernigan, J. A. (2005) · Clinical Infectious Diseases · doi:10.1086/430909 · Cited by 459
Ribosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449
Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes: MLSKO genes
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377
Self-citation
Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP‐binding transport super‐gene family
Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S., & Wootton, J. C. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00696.x · Cited by 358
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P. M., Darfeuille–Michaud, A., Perroux, R., & Cluzel, R. A. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.3.323 · Cited by 353
Proliferation and significance of clinically relevant β‐lactamases
Bush, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12023 · Cited by 338
The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
Arthur, M., Molinas, C., & Courvalin, P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.8.2582-2591.1992 · Cited by 338
Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Self-citation
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 335
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Stryjewski, M. E., & Corey, G. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit613 · Cited by 334
Cytosolic Intermediates for Cell Wall Biosynthesis and Degradation Control Inducible β-Lactam Resistance in Gram-Negative Bacteria
Jacobs‐Wagner, C., Frère, J., & Normark, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81928-5 · Cited by 334
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
Bayer, A. S., Schneider, T., & Sahl, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06819.x · Cited by 311
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 310
Plasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306
Bacterial cell‐wall recycling
Johnson, J. W., Fisher, J. F., & Mobashery, S. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06813.x · Cited by 287
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286
Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa Infections
Quinn, J. P., Dudek, E. J., DiVincenzo, C. A., Lucks, D. A., & Lerner, S. A. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.2.289 · Cited by 276
An Enterococcus faecalis ABC Homologue (Lsa) Is Required for the Resistance of This Species to Clindamycin and Quinupristin-Dalfopristin
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
The ABCD’s of β-lactamase nomenclature
Bush, K. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0640-7 · Cited by 239
MRSA: the first half century
Moellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236
IS Ecp1B -Mediated Transposition of bla CTX-M in Escherichia coli
Poirel, L., Lartigue, M.-F., Decousser, J., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.447-450.2005 · Cited by 228
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
Mendes, R. E., Deshpande, L. M., & Jones, R. N. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.04.002 · Cited by 221
Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance
Hobbs, E. C., Yin, X., Paul, B. J., Astarita, J. L., & Storz, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210093109 · Cited by 220
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits
Manson, J. M., Hancock, L. E., & Gilmore, M. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000139107 · Cited by 192
Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids
Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192
Self-citation
Genomic Basis for Methicillin Resistance in Staphylococcus aureus
Hiramatsu, K., Ito, T., Tsubakishita, S., Sasaki, T., Takeuchi, F., Morimoto, Y., Katayama, Y., Matsuo, M., Kuwahara-Arai, K., Hishinuma, T., et al. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.2.117 · Cited by 189
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182
Self-citation
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis
Visalli, M. A., Murphy, E., Projan, S. J., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.665-669.2003 · Cited by 165
Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
Zhang, T., Muraih, J. K., Tishbi, N., Herskowitz, J., Victor, R. L., Silverman, J., Uwumarenogie, S., Taylor, S. D., Palmer, M., & Mintzer, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554444 · Cited by 162
Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance
Doménech-Sánchez, A., Martínez-Martínez, L., Hernández-Allés, S., del Carmen Conejo, M., Pascual, A., Tomás, J. M., Albertí, S., & Benedí, V. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3332-3335.2003 · Cited by 151
Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)
Li, W., Atkinson, G. C., Thakor, N. S., Allas, Ü., Lu, C.-C., Chan, K.-Y., Tenson, T., Schulten, K., Wilson, K. S., Hauryliuk, V., et al. (2013) · Nature Communications · doi:10.1038/ncomms2470 · Cited by 147
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Díaz, L., Tran, T. T., Munita, J. M., Miller, W. R., Rincón, S., Carvajal, L. P., Wollam, A., Reyes, J., Panesso, D., Rojas, N. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02686-14 · Cited by 143
Self-citation
Detection and Prevalence of Active Drug Efflux Mechanism in Various Multidrug-Resistant Klebsiella pneumoniae Strains from Turkey
Hasdemir, U. O., Chevalier, J., Nordmann, P., & Pagès, J.-M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2701-2706.2004 · Cited by 131
Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
Watanabe, Y., Cui, L., Katayama, Y., Kozue, K., & Hiramatsu, K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02144-10 · Cited by 127
Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy
Tran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125
Self-citation
Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐Resistant Staphylococcus aureus Isolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance
Bae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606027 · Cited by 122
Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., Murray, B. E., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-12 · Cited by 118
Self-citation
In-Depth Profiling of the LiaR Response of Bacillus subtilis
Wolf, D., Kalamorz, F., Wecke, T., Juszczak, A., Mäder, U., Homuth, G., Jordan, S., Kirstein, J., Hoppert, M., Voigt, B., et al. (2010) · Journal of Bacteriology · doi:10.1128/jb.00543-10 · Cited by 116
Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim
FLENSBURG, J., & SKÖLD, O. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb10664.x · Cited by 103
Tedizolid for the Management of Human Infections: In Vitro Characteristics
Locke, J. B., Zurenko, G. E., Shaw, K. J., & Bartizal, K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit616 · Cited by 101
A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis
Reyes, J., Panesso, D., Tran, T. T., Mishra, N. N., Cruz, M. R., Munita, J. M., Singh, K. V., Yeaman, M. R., Murray, B. E., Shamoo, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu602 · Cited by 94
Self-citation
Vancomycin-Dependent Enterococcus faecalis Clinical Isolates and Revertant Mutants
Van Bambeke, F., Chauvel, M., Reynolds, P. E., Fraimow, H. S., & Courvalin, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.41 · Cited by 88
Assembly and operation of bacterial tripartite multidrug efflux pumps
Du, D., van Veen, H. W., & Luisi, B. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.010 · Cited by 86
The Lipid-Modifying Multiple Peptide Resistance Factor Is an Oligomer Consisting of Distinct Interacting Synthase and Flippase Subunits
Ernst, C. M., Kuhn, S., Slavetinsky, C. J., Krismer, B., Heilbronner, S., Gekeler, C., Kraus, D., Wagner, S., & Peschel, A. (2015) · mBio · doi:10.1128/mbio.02340-14 · Cited by 71
Failure of High-Dose Daptomycin for Bacteremia Caused by Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions
Munita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., Adachi, J. A., Bayer, A. S., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu642 · Cited by 70
Self-citation
A liaF Codon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis
Munita, J. M., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., & Arias, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00021-13 · Cited by 70
Self-citation
Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid
Zervos, M. J., & Schaberg, D. R. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.446 · Cited by 68
In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin
Nannini, E. C., Singh, K. V., Arias, C. A., & Murray, B. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00856-13 · Cited by 64
Self-citation
Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated β-Lactam Resistance
Schmidtke, A. J., & Hanson, N. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01458-05 · Cited by 62
Reversal of activity of trimethoprim against Gram-positive cocci by thymidine, thymine and ‘folates’
Hamilton-Miller, J. M. T. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.1.35 · Cited by 49
Genes homologous to glycopeptide resistance van A are widespread in soil microbial communities
Guardabassi, L., & AgersÃ¸, Y. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00270.x · Cited by 47
The disruption of prenylation leads to pleiotropic rearrangements in cellular behavior in Staphylococcus aureus
Krute, C. N., Carroll, R. K., Rivera, F. E., Weiss, A., Young, R. M., Shilling, A., Botlani, M., Varma, S., Baker, B. J., & Shaw, L. N. (2015) · Molecular Microbiology · doi:10.1111/mmi.12900 · Cited by 17
Vancomycin sensing
Arthur, M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.356 · Cited by 13

Flagged first, then by citations

Research works printed but not linked: 4

World Health Organization, 2014, Antimicrobial Resistance: Global Report on Surveillance 2014. WHO, Geneva Switzerland
Centers for Disease Control and Prevention, 2013, Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention, 2013. CDC, Atlanta, GA
The Review on Antimicrobial Resistance, 2014, Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations
Clinical and Laboratory Standards Institute, 2014, Performance Standards for Antimicrobial Susceptibility Testing; 24th informational supplement, CLSI document M100-S24. CLSI, Wayne, PA

Sorted by citations

Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,680
Phage Therapy in the Postantibiotic Era
Altamirano, F. L. G., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 1,073
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
Chaturvedi, P., Shukla, P., Giri, B. S., Chowdhary, P., Chandra, R., Gupta, P., & Pandey, A. (2021) · Environmental Research · doi:10.1016/j.envres.2020.110664 · Cited by 718
Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting
Morris, S., & Cerceo, E. A. (2020) · Antibiotics · doi:10.3390/antibiotics9040196 · Cited by 295
Antibiotic resistance in Salmonella spp. isolated from poultry: A global overview
Castro-Vargas, R. E., Herrera‐Sánchez, M. P., Rodríguez‐Hernández, R., & Rondón‐Barragán, I. S. (2020) · Veterinary World · doi:10.14202/vetworld.2020.2070-2084 · Cited by 254

See all 433

Authors: Munita, J. M., & Arias, C. A.
Affiliations: Universidad del Desarrollo (CL)
Department of Internal Medicine, Division of Infectious Diseases; University of Texas Medical School at Houston; Houston TX 77030
ORCID: Munita, Jose M.
Venue: Virulence Mechanisms of Bacterial Pathogens
Publisher: ASM Press
Published: 2016-04-09
Pages: 481-511
DOI: 10.1128/9781555819286.ch17
OpenAlex: W4211042139
Cited by: 421
References: 106
Citations by year: 2026: 57 · 2025: 71 · 2024: 87 · 2023: 44 · 2022: 42 · 2021: 50 · 2020: 36 · 2019: 21 · 2018: 9 · 2017: 3 · 2016: 1
FWCI: 15.59
Type: book chapter
Language: en
Open access: closed
Locations: ASM Press eBooks (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords: antibiotic resistance, antibiotic resistance mechanisms, pathogenic bacteria, antimicrobial agents, public health risk, critically ill patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanisms of Antibiotic Resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks